ISSN: 2168-9652

Biochemistry & Physiology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
Divya Patel
Divya Patel

Divya Patel, Ph.D
Center for Cancer Research and Therapeutic Development
Clark Atlanta University,
Atlanta, Georgia

Biography

Dr. Divya Patel received her Master’s in Microbiology and Ph.D. in Biochemistry from The Maharaja Sayajirao University of Baroda, Baroda, India. She then moved to USA to pursue postdoctoral research at Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL where her work focused on generating RNA Aptamers against immunotherapeutically important target molecules belonging to the tumor necrosis factor (TNF) receptor super family. Dr. Patel is currently continuing her postdoctoral training at Clark Atlanta University’s Center for Cancer Research and Therapeutic Development (CCRTD) and her research concentrates on exploring the role of members of bHLH family of transcription factors in prostate cancer development and progression.

Research Interest

My research focusses on human medicine with the goal of identifying key disease (specifically cancer) mechanisms and targets. With this aim, my current research work concentrates on exploring the role of members of bHLH family of transcription factors, specifically E2A (TCF3) in prostate cancer development and progression. E2A is known to regulate transcription of target genes by homo- or heterodimerization with other bHLH proteins such as MyoD, Mash, NeuroD and Id family of helix loop helix proteins. In general, E2A promotes cell differentiation, acts as a negative regulator of cell proliferation in normal cells and cancer cell lines and is required for normal B-cell development. Given the diverse biological pathways regulated/ influenced by E2A little is known about its expression in prostate cancer. My project therefore involves trying to investigate the mechanism of regulation of E2A in prostate cancer which could either be epigenetic or by gene fusion and chromosomal translocations or androgen receptor dependent. I was also involved in generating RNA Aptamers against immunotherapeutically important target molecules belonging to the tumor necrosis factor (TNF) receptor super family such as OX40 (CD134, TNFRSF4) and 4-1BB (CD137, TNFRSF9). Aptamers are single stranded oligonucleotides capable of binding to their target molecules with high affinity and specificity. They are derived by a process called SELEX (Systematic Evolution of Ligands by EXponential enrichment). Unlike monoclonal antibodies, aptamers have low molecular weights, are chemically synthesized and non immunogenic. Thus, aptamers can serve as promising probes for molecular recognition for diagnostic and therapeutic purposes.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version